产品说明书

7-epi-Taxol

Print
Chemical Structure| 105454-04-4 同义名 : 7-epi-Paclitaxel
CAS号 : 105454-04-4
货号 : A495321
分子式 : C47H51NO14
纯度 : 98%
分子量 : 853.906
MDL号 : MFCD07783713
存储条件:

粉末 Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(122.96 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 7-Epitaxol, as an anticancer drug, can promote tubulin polymerization and stabilize microtubules from depolymerizing[3].In vivo, administration of 7-Epitaxol over four cumulative doses at 2 mg/kg induced terminal arbor degeneration (TAD) in only the intraepidermal DRG axons of ratsLisse TS, Elias LJ, Pellegrini AD, Martin PB, Spaulding EL, Lopes O, Brochu EA, Carter EV, Waldron A, Rieger S. Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish. Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2189-98. doi: 10.1073/pnas.1525096113. Epub 2016 Mar 28. PMID: 27035978; PMCID: PMC4839466.https://pubmed.ncbi.nlm.nih.gov/27035978/. In vitro, 7-Epitaxoll treated(30 μm) PC1/3 KD macrophages secreted additional antitumoral factors active against glioma cells[4].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.17mL

0.23mL

0.12mL

5.86mL

1.17mL

0.59mL

11.71mL

2.34mL

1.17mL

参考文献

[1]Royer I, Alvinerie P, et al. Paclitaxel metabolites in human plasma and urine: identification of 6 alpha-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 1995;9(6):495-502.

[2]Ringel I, Horwitz SB. Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium. J Pharmacol Exp Ther. 1987 Aug;242(2):692-8.

[3]Meng Z, Lv Q, Lu J, Yao H, Lv X, Jiang F, Lu A, Zhang G. Prodrug Strategies for Paclitaxel. Int J Mol Sci. 2016 May 23;17(5):796. doi: 10.3390/ijms17050796. PMID: 27223283; PMCID: PMC4881612.

[4]Duhamel M, Rose M, Rodet F, Murgoci AN, Zografidou L, Régnier-Vigouroux A, Vanden Abeele F, Kobeissy F, Nataf S, Pays L, Wisztorski M, Cizkova D, Fournier I, Salzet M. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies. Mol Cell Proteomics. 2018 Jun;17(6):1126-1143. doi: 10.1074/mcp.RA117.000443. Epub 2018 Mar 12. PMID: 29531019; PMCID: PMC5986247.